| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $16.7M | -67.3% |
| SG&A Expense | $13.7M | +0.0% |
| Pre-tax Income | -$25.2M | +60.1% |
| Income Tax | $1K | +0.0% |
| Net Income | -$25.2M | +60.1% |
| EPS (Basic) | -$3.13 | +98.2% |
| EPS (Diluted) | -$3.13 | +98.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $250.2M | +988.8% |
| Short-term Investments | $45.0M | +797.0% |
| Current Assets | $308.4M | +968.0% |
| Total Assets | $312.9M | +833.2% |
| Current Liabilities | $7.4M | -8.2% |
| Total Liabilities | $11.6M | -15.9% |
| Stockholders' Equity | $301.3M | +418.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$35.2M | +33.6% |
| Capital Expenditures | $52K | -93.2% |
| Investing Cash Flow | -$39.9M | -271.7% |
| Financing Cash Flow | $302.6M | +689.7% |
| Free Cash Flow | -$35.3M | +34.5% |